Glaxosmithkline Plc Nkarta, Inc. (NKTX) insider trading activity

NKTX Quotes by TradingView

GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
Jul 14 2020
BUY
Open market or private purchase
$14,999,994 $18.0 p/Share
833,333
Jul 14 2020
BUY
Conversion of derivative security
-
2,317,399

Also insider at

TPTX
Turning Point Therapeutics, Inc.
Director
CRSP
CRISPR Therapeutics AG Healthcare
> 10% Shareholder
PGNY
Progyny, Inc. Healthcare
> 10% Shareholder
CCXI
ChemoCentryx, Inc.
LYEL
Lyell Immunopharma, Inc. Healthcare
> 10% Shareholder
INVA
Innoviva, Inc. Healthcare
> 10% Shareholder
MORF
Morphic Holding, Inc. Healthcare
Director
TBPH
Theravance Biopharma, Inc. Healthcare
BCYC
BICYCLE THERAPEUTICS plc Healthcare
> 10% Shareholder
FULC
Fulcrum Therapeutics, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
> 10% Shareholder
CVRX
CVRx, Inc. Healthcare
> 10% Shareholder
DBTX
Decibel Therapeutics, Inc. Healthcare
Director
SPRO
Spero Therapeutics, Inc. Healthcare
> 10% Shareholder
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
> 10% Shareholder
TBIO
Translate Bio, Inc. Healthcare
> 10% Shareholder
PAND
Pandion Therapeutics, Inc.
Director
PRNB
Principia Biopharma Inc.
LQDA
Liquidia Technologies Inc
GP

Glaxosmithkline PLC

Director
Brentford Middlesex, X0

Track Institutional and Insider Activities on NKTX

Follow Nkarta, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NKTX shares.

Notify only if

Insider Trading

Get notified when an Nkarta, Inc. insider buys or sells NKTX shares.

Notify only if

News

Receive news related to Nkarta, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NKTX